ALPS Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Buy |
+27,045
| New | +$222K | ﹤0.01% | 1001 |
|
|
2023
Q2 | – | Sell |
-28,632
| Closed | -$541K | – | 1026 |
|
|
2023
Q1 | $541K | Sell |
28,632
-713
| -2% | -$13.5K | ﹤0.01% | 584 |
|
|
2022
Q4 | $666K | Buy |
29,345
+5,713
| +24% | +$130K | 0.01% | 540 |
|
|
2022
Q3 | $625K | Sell |
23,632
-1,956
| -8% | -$51.7K | 0.01% | 557 |
|
|
2022
Q2 | $632K | Sell |
25,588
-18,550
| -42% | -$458K | 0.01% | 543 |
|
|
2022
Q1 | $1.47M | Sell |
44,138
-5,353
| -11% | -$178K | 0.02% | 276 |
|
|
2021
Q4 | $1.62M | Sell |
49,491
-2,721
| -5% | -$89K | 0.02% | 308 |
|
|
2021
Q3 | $2.19M | Sell |
52,212
-3,772
| -7% | -$158K | 0.02% | 302 |
|
|
2021
Q2 | $2.18M | Sell |
55,984
-20,904
| -27% | -$812K | 0.02% | 308 |
|
|
2021
Q1 | $2.62M | Buy |
76,888
+9,407
| +14% | +$321K | 0.03% | 233 |
|
|
2020
Q4 | $3.06M | Buy |
+67,481
| New | +$3.06M | 0.03% | 213 |
|
|
2019
Q3 | – | Sell |
-6,657
| Closed | -$342K | – | 965 |
|
|
2019
Q2 | $342K | Sell |
6,657
-352
| -5% | -$18.1K | ﹤0.01% | 807 |
|
|
2019
Q1 | $402K | Buy |
7,009
+605
| +9% | +$34.7K | ﹤0.01% | 695 |
|
|
2018
Q4 | $269K | Sell |
6,404
-266
| -4% | -$11.2K | ﹤0.01% | 825 |
|
|
2018
Q3 | $504K | Buy |
+6,670
| New | +$504K | ﹤0.01% | 596 |
|